Skip to main content
Glama

Quotable

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "drug"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Even with readOnly/openWorld/idempotent annotations, the description adds substantial behavioral context: each call cascades through several lookup endpoints, LEI/FIGI enrichment degrades gracefully, unresolved identifiers are explicitly listed under `unresolved`, identifiers are labelled with their source, and non-ticker instruments resolve when appropriate. This goes far beyond what annotations indicate.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with examples and the core purpose, but it is extremely dense and runs on as a single wall of text with many parentheticals. There is a lot of valuable information, but it could be organized into focused bullets or shorter sentences to improve scannability. Some redundancy exists between the opening example list and the later input-format guidance.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool has two parameters, no output schema, and no explicit per-parameter format hints in the schema, the description is remarkably complete. It covers supported entity types, accepted input forms, resolution behavior, candidate disambiguation, source labeling, unresolved identifiers, graceful degradation, and why internal cascading reduces manual lookups. An agent has all the information needed to invoke it correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although schema coverage is 100%, the description greatly enriches the parameter meanings. It explains what `value` may contain for company (ticker, CIK, ISIN, or name) versus drug (brand or generic), gives concrete examples, and adds a critical warning to pass only the entity name, not the full noun phrase, because trailing security-class words will fail the FIGI lookup. This is exactly the kind of semantic guidance an agent needs.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: resolve a user-spoken name into canonical/official identifiers that other tools require as input. It opens with concrete example queries ('What's the ticker for...', 'find the CIK for...') and the 'Use FIRST whenever you have a name but need an ID' rule makes the tool's role unmistakable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives an explicit when-to-use directive: 'Use FIRST whenever you have a name but need an ID.' It also scopes supported entity types (company, drug) and explains when the tool should not assert a single answer (when a bond issuer name matches multiple instruments, it returns candidates). However, it does not name sibling tools or state when-not-to-use conditions such as 'use entity_profile if you need a full profile rather than an ID.'

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Quotable toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

The ask_pipeworx family (ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded) is highly overlapping—two of them are explicitly identical right now—and the six polymarket_* tools plus bet_research create unclear boundaries between prediction-market analysis tools. Company-focused tools (entity_profile, compare_entities, recent_changes, resolve_entity) also partially overlap in what they fetch, making tool selection error-prone.

Naming Consistency4/5

Most tool names follow a clear snake_case pattern with descriptive verbs (search_quotes, resolve_entity, validate_claim, subscribe, unsubscribe). There is good use of family prefixes like polymarket_* and pipeworx_*, though the Pipeworx family mixes prefix and suffix placement (ask_pipeworx vs. pipeworx_feedback), which is a minor inconsistency.

Tool Count2/5

35 tools is far too many for a server named 'Quotable', especially since only 4 tools (get_authors, list_tags, random_quote, search_quotes) relate to quotes. The rest span data lookup, prediction markets, memory, subscriptions, AI visibility, and dependency scanning—an extremely broad, unfocused scope that overwhelms the apparent purpose.

Completeness3/5

The quote-related surface is minimal but functional (random, search, authors, tags), though missing obvious operations like get_quote_by_id. The data-lookup and prediction-market domains are thoroughly covered with grounding, research, arbitrage, and fill-risk tools, so the broader set is complete—but it does not serve the server's stated identity as a quotes provider.

Resources